Description
• রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।
TELMIVAS 40 MG is indicated for:
-
Treatment of hypertension (high blood pressure)
-
Reducing cardiovascular risk in patients unable to take ACE inhibitors
-
Protection of renal function in hypertensive type 2 diabetic patients with proteinuria
It helps reduce the risk of stroke, heart attack, and kidney failure in high-risk patients.
Pharmacology:
Telmisartan is an angiotensin II receptor antagonist (ARB) that specifically blocks the AT1 receptor, preventing the vasoconstrictor and aldosterone-secreting effects of angiotensin II. This results in vasodilation, reduction in blood pressure, and decreased workload on the heart.
Telmisartan has a long half-life (approximately 24 hours), allowing for once-daily dosing and consistent blood pressure control.
Dosage:
-
Initial dose (adults): 40 mg once daily
-
May be increased to 80 mg once daily depending on patient response
-
Can be used alone or with other antihypertensives (e.g., hydrochlorothiazide)
-
No dosage adjustment generally needed in elderly or patients with mild-to-moderate renal impairment
Administration:
-
Take orally once daily with or without food
-
Try to take at the same time each day for best results
-
Continue taking even if you feel well, as high blood pressure often has no symptoms
Interaction:
-
Increased risk of hyperkalemia with potassium supplements or potassium-sparing diuretics
-
NSAIDs may reduce antihypertensive effect and impair kidney function
-
Lithium levels may increase—monitor closely
-
Use caution when combining with other blood pressure medications to avoid hypotension
Contraindications:
-
Hypersensitivity to Telmisartan or any excipient
-
Pregnancy, especially 2nd and 3rd trimesters (can harm or kill fetus)
-
Severe hepatic impairment
-
Use with aliskiren in patients with diabetes or renal impairment
Side Effects:
Common:
-
Dizziness, low blood pressure (hypotension), fatigue
-
Back pain, sinusitis
Less common: -
Hyperkalemia, renal impairment, bradycardia
-
Rare: angioedema, liver dysfunction
Regular monitoring of blood pressure, electrolytes, and renal function is advised during long-term use.
Pregnancy & Lactation:
-
Pregnancy: Contraindicated. Telmisartan may cause fetal injury or death if used during 2nd or 3rd trimester.
-
Lactation: Not recommended; insufficient data available—either stop breastfeeding or discontinue the drug.
Therapeutic Class:
-
Angiotensin II Receptor Blockers (ARBs)
-
Antihypertensive agents
Storage Conditions:
-
Store at below 30°C, protected from light and moisture
-
Keep out of reach of children
-
Do not use expired or damaged tablets
.jpg)
Change Language